Spotlight

Dr Celia Caulcott

UCL launches £50 million technology investment fund

UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.

Find out more




follow us on twitter


Spirogen sold to AstraZeneca

16 October 2013

AstraZeneca to pay $440m for UK biotech business
Pharmaceutical group makes acquisition in oncology group spun out of university
Read: Guardian

AstraZeneca Buys Spirogen for $440 Million
MedImmune Unit Also Enters Deal with ADC Therapeutics
Read: Wall Street Journal